CoChat

Host blood RNA signatures predict the outcome of tuberculosis treatment

Open access
Thompson, Ethan G., Du, Ying, Malherbe, Stephanus T., Shankar, Smitha, Braun, Jackie, Valvo, Joe, Ronacher, Katharina, Tromp, Gerard, Tabb, David L., Alland, David, Shenai, Shubhada, Via, Laura E., Warwick, James, Aderem, Alan, Scriba, Thomas J., Winter, Jill, Walzl, Gerhard, Zak, Daniel E., Du Plessis, Nelita, Loxton, Andre G., Chegou, Novel N., Lee, Myungsun · 2017 · Tuberculosis
Cited by 181

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Biomarkers for tuberculosis treatment outcome will assist in guiding individualized treatment and evaluation of new therapies. To identify candidate biomarkers, RNA sequencing of whole blood from a well-characterized TB treatment cohort was performed. Application of a validated transcriptional correlate of risk for TB revealed symmetry in host gene expression during progression from latent TB infection to active TB disease and resolution of disease during treatment, including return to control levels after drug therapy. The symmetry was also seen in a TB disease signature, constructed from the TB treatment cohort, that also functioned as a strong correlate of risk. Both signatures identified patients at risk of treatment failure 1-4 weeks after start of therapy. Further mining of the transcriptomes revealed an association between treatment failure and suppressed expression of mitochondrial genes before treatment initiation, leading to development of a novel baseline (pre-treatment) signature of treatment failure. These novel host responses to TB treatment were integrated into a five-gene real-time PCR-based signature that captures the clinically relevant responses to TB treatment and provides a convenient platform for stratifying patients according to their risk of treatment failure. Furthermore, this 5-gene signature is shown to correlate with the pulmonary inflammatory state (as measured by PET-CT) and can complement sputum-based Gene Xpert for patient stratification, providing a rapid and accurate alternative to current methods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tube.2017.08.004

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 8 references

Cited by

See all 181

Metadata

Authors
Thompson, E. G., Du, Y., Malherbe, S. T., Shankar, S., Braun, J., Valvo, J., Ronacher, K., Tromp, G., Tabb, D. L., Alland, D., Shenai, S., Via, L. E., Warwick, J., Aderem, A., Scriba, T. J., Winter, J., Walzl, G., Zak, D. E., Du Plessis, N., Loxton, A. G., Chegou, N. N., & Lee, M.
Venue
Tuberculosis
Publisher
Elsevier BV
Published
2017-12
Volume
107
Pages
48-58
ISSN
1472-9792 (ISSN-L)
OpenAlex
W2742907526
Cited by
181
References
8
FWCI
10.23
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Host blood RNA signatures predict the outcome of tuberculosis treatment. https://app.cochat.ai/papers/10.1016/j.tube.2017.08.004
The paper
Thompson, E. G., Du, Y., Malherbe, S. T., Shankar, S., Braun, J., Valvo, J., Ronacher, K., Tromp, G., Tabb, D. L., Alland, D., Shenai, S., Via, L. E., Warwick, J., Aderem, A., Scriba, T. J., Winter, J., Walzl, G., Zak, D. E., Du Plessis, N., . . . Lee, M. (2017). Host blood RNA signatures predict the outcome of tuberculosis treatment. Tuberculosis. https://doi.org/10.1016/j.tube.2017.08.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.